Loading
Latest filing published 18 Sept 2019 for Kalytera Therapeutics, Inc., €68k.
No signal scores available.
All filings by Robert Edward Farrell on record concern Kalytera Therapeutics, Inc. Over a trading history stretching from 30 December 2016 to 13 September 2019, the count stands at 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 18 September 2019, the filings show a transaction worth €68k in Kalytera Therapeutics, Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations